{"nct_id":"NCT01235221","title":"Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.","status":"COMPLETED","status_verified_date":"2014-07","start_date":"2010-12","start_date_type":null,"primary_completion_date":"2012-06","primary_completion_date_type":"ACTUAL","completion_date":"2012-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BIIB"]}